These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30799622)

  • 21. Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.
    Sánchez-Murcia PA; Mills A; Cortés-Cabrera Á; Gago F
    J Comput Aided Mol Des; 2019 Jul; 33(7):627-644. PubMed ID: 31152293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.
    Risinger AL; Jackson EM; Polin LA; Helms GL; LeBoeuf DA; Joe PA; Hopper-Borge E; Ludueña RF; Kruh GD; Mooberry SL
    Cancer Res; 2008 Nov; 68(21):8881-8. PubMed ID: 18974132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taccalonolides: A Novel Class of Microtubule-Stabilizing Anticancer Agents.
    Chen X; Winstead A; Yu H; Peng J
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation.
    Mao J; Luo QQ; Zhang HR; Zheng XH; Shen C; Qi HZ; Hu ML; Zhang H
    Chem Biol Interact; 2022 Jan; 352():109784. PubMed ID: 34932952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin.
    Bhattacharya S; Kumar NM; Ganguli A; Tantak MP; Kumar D; Chakrabarti G
    PLoS One; 2013; 8(10):e76286. PubMed ID: 24116100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
    Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
    J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
    Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
    Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taccalonolides: a microtubule stabilizer poses a new puzzle with old pieces.
    Sackett DL; Fojo T
    Cell Cycle; 2011 Oct; 10(19):3233-4. PubMed ID: 21946521
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.
    Rohena CC; Mooberry SL
    Nat Prod Rep; 2014 Mar; 31(3):335-55. PubMed ID: 24481420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ELR510444, a novel microtubule disruptor with multiple mechanisms of action.
    Risinger AL; Westbrook CD; Encinas A; Mülbaier M; Schultes CM; Wawro S; Lewis JD; Janssen B; Giles FJ; Mooberry SL
    J Pharmacol Exp Ther; 2011 Mar; 336(3):652-60. PubMed ID: 21148249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1
    Wang C; Li Y; Liu Z; Wang Z; Liu Z; Man S; Zhang Y; Bao K; Wu Y; Guan Q; Zuo D; Zhang W
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):549-560. PubMed ID: 33522315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamics.
    Al-Hamashi AA; Koranne R; Dlamini S; Alqahtani A; Karaj E; Rashid MS; Knoff JR; Dunworth M; Pflum MKH; Casero RA; Perera L; Taylor WR; Tillekeratne LMV
    Bioorg Chem; 2021 Nov; 116():105297. PubMed ID: 34509798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An antitubulin agent BCFMT inhibits proliferation of cancer cells and induces cell death by inhibiting microtubule dynamics.
    Rai A; Surolia A; Panda D
    PLoS One; 2012; 7(8):e44311. PubMed ID: 22952952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
    Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
    Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Podoverine A--a novel microtubule destabilizing natural product from the Podophyllum species.
    Tran TT; Gerding-Reimers C; Schölermann B; Stanitzki B; Henkel T; Waldmann H; Ziegler S
    Bioorg Med Chem; 2014 Sep; 22(18):5110-6. PubMed ID: 24530033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estradiol dimer inhibits tubulin polymerization and microtubule dynamics.
    Jurášek M; Černohorská M; Řehulka J; Spiwok V; Sulimenko T; Dráberová E; Darmostuk M; Gurská S; Frydrych I; Buriánová R; Ruml T; Hajdúch M; Bartůněk P; Dráber P; Džubák P; Drašar PB; Sedlák D
    J Steroid Biochem Mol Biol; 2018 Oct; 183():68-79. PubMed ID: 29803726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin.
    Raccor BS; Vogt A; Sikorski RP; Madiraju C; Balachandran R; Montgomery K; Shin Y; Fukui Y; Jung WH; Curran DP; Day BW
    Mol Pharmacol; 2008 Mar; 73(3):718-26. PubMed ID: 18073274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of facile amides-functionalized rhodanine-3-acetic acid derivatives as potential anticancer agents by disrupting microtubule dynamics.
    Zhou X; Liu J; Meng J; Fu Y; Wu Z; Ouyang G; Wang Z
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1996-2009. PubMed ID: 34525898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton.
    Zhang J; Zhou J; Ren X; Diao Y; Li H; Jiang H; Ding K; Pei D
    Invest New Drugs; 2012 Apr; 30(2):490-507. PubMed ID: 21080210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors.
    Kraus Y; Glas C; Melzer B; Gao L; Heise C; Preuße M; Ahlfeld J; Bracher F; Thorn-Seshold O
    Eur J Med Chem; 2020 Jan; 186():111865. PubMed ID: 31735573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.